Aduhelm (aducanumab) is an intravenously administered amyloid beta-directed antibody for the treatment of Alzheimer disease.
Aduhelm (Aducanumab) for Alzheimer Disease
read more
Publications
Researched and Curated by Clinical and Scientific Experts.Every Hayes clinical evidence report is developed by experienced teams that have been trusted by healthcare decision makers since 1989. Here is a sampling of our content that is being used every day to inform defensible, evidence-based decisions by payers and providers.
Not all reports are available for public preview. For more information, please contact us.
Lecanemab for Alzheimer Disease
Lecanemab (formerly, BAN2401) is an investigational, intravenously administered anti-amyloid beta (Aβ) protofibril antibody proposed for the treatment of early Alzheimer disease.
RhinAer Procedure (Aerin Medical) for Treatment of Chronic Rhinitis
This report addresses whether full-text clinical studies, systematic reviews, and clinical practice guidelines and position statements support the use of RhinAer (Aerin Medical) for improvement of symptoms of chronic rhinitis.
Pharmacogenomic Testing for Attention-Deficit/Hyperactivity Disorder Treatment
This report evaluates the clinical utility of pharmacogenomic testing to inform the selection or dose of medications for individuals diagnosed with attention-deficit/hyperactivity disorder (ADHD) to improve clinical outcomes.
Percutaneous Ultrasonic Tenotomy (Tenex Health TX) for Treatment of Elbow Tendinopathy
This report addresses whether full-text clinical studies, systematic reviews, and clinical practice guidelines and position statements support the use of Tenex (Tenex Health TX) to administer percutaneous ultrasonic tenotomy to reduce pain and improve quality of life and function in patients with elbow tendinopathy.
Mavacamten for Obstructive Hypertrophic Cardiomyopathy
Mavacamten is an investigational oral myosin inhibitor that targets the underlying molecular mechanisms of hypertrophic cardiomyopathy (HCM). It is proposed for the treatment of patients with symptomatic obstructive HCM.
Cala Trio (Cala Health, Inc.) for Treatment of Essential Tremor
This report addresses whether full-text clinical studies, systematic reviews, and clinical practice guidelines and position statements support the use of Cala Trio (Cala Health Inc.) for treatment of essential tremor.
Middle Cluneal Nerve Block for Treatment of Low Back Pain
This report addresses whether full-text clinical studies, systematic reviews, and clinical practice guidelines and position statements support the use of medial cluneal nerve (MCN) blocks for patients with lower back pain (LBP) thought to be due to MCN entrapment (MCN-E).
Leqvio (Inclisiran) for Hypercholesterolemia
Leqvio (inclisiran) is a subcutaneously administered, small interfering RNA (siRNA) directed to PCSK9 (proprotein convertase subtilisin kexin type 9) mRNA indicated as an adjunct to diet and maximally tolerated statin therapy for the treatment of adults with heterozygous familial hypercholesterolemia (HeFH) or clinical atherosclerotic cardiovascular disease (ASCVD), who requi…
Intraoperative Neuromonitoring for Lumbar Spinal Fusion and Discectomy
Focus of Report: This report focuses on intraoperative neuromonitoring (IONM) for the detection and prevention of surgical manipulations that could cause nerve damage during lumbar spinal discectomy alone or discectomy plus fusion.
Technology Description: During discectomy or fusion of…